|
Volumn 48, Issue 2, 2002, Pages 115-117
|
The effect of combined therapy with immunoadsorption and high-dose intravenous methylprednisolone on myasthenia gravis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLINERGIC RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
PREDNISOLONE;
ADULT;
ANTIBODY TITER;
ARTICLE;
ASSOCIATION;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG MEGADOSE;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
HUMAN TISSUE;
IMMUNOADSORPTION;
INFORMED CONSENT;
LONG TERM CARE;
MALE;
MYASTHENIA GRAVIS;
PLASMAPHERESIS;
PRIORITY JOURNAL;
SHORT COURSE THERAPY;
STATISTICAL ANALYSIS;
THYMECTOMY;
ADULT;
FEMALE;
HUMANS;
IMMUNOSORBENT TECHNIQUES;
INJECTIONS, INTRAVENOUS;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
MYASTHENIA GRAVIS;
NEUROPROTECTIVE AGENTS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 0036375171
PISSN: 00143022
EISSN: None
Source Type: Journal
DOI: 10.1159/000062987 Document Type: Article |
Times cited : (13)
|
References (17)
|